Too often, cystic fibrosis (CF) patients or their caregivers do not follow proper hygiene procedures when cleaning, disinfecting and storing…
Articles by Teresa Carvalho, MS
The Cystic Fibrosis Foundation (CFF) has given Beyond Air up to $2.17 million to test its portable inhaled nitric…
Pharmaxis announced that a first batch of Bronchitol (mannitol), its dry powder and mucus clearing treatment for cystic fibrosis…
Two new sites for the extension of a Phase 2b trial testing an immediate release capsule form of MS1819 in treating exocrine…
The Cystic Fibrosis Foundation (CFF) has given Kinnear Pharmaceuticals up to $3 million to conduct the laboratory tests of…
Using bronchoscopy to examine the airways and the surrounding tissues of people with cystic fibrosis, coupled with the collecting of…
The U.S. Food and Drug Administration (FDA) has approved the dry inhalation powder Bronchitol (mannitol) as a maintenance…
The National Board for Respiratory Care (NBRC) has launched “CHOOSE ONE: Every Breath Counts Campaign,” a fundraising initiative…
Ionis Pharmaceuticals’ investigational inhaled therapy IONIS-ENAC-2.5Rx showed promise in a Phase 1/2a study as a potential new treatment…
Twincer, a dry powder inhaler (DPI), was shown to be a more attractive approach for the inhalation of …